Furthermore, DJ‐1 deficiency decreased the CD4+:CD8+ T‐cell ratio and promoted the development of regulatory T cells 21 that is associated with a positive outcome in CRC 22, suggesting that DJ‐1 promotes tumor progression by inhibiting tumor immunology in CRC. The gene discussed is CD8A; the disease is neoplasm.